Nowadays, single-cell RNA sequencing technologies and related bioinformatics tools are emerging as essential devices for dissecting tumors at single-cell resolution and understanding carcinogenesis and drug response mechanisms, representing a...
30-Nov-2021 1:35 PM EST Add to Favorites
A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as...
23-Nov-2021 10:10 AM EST Add to Favorites
Professor Antonio Giordano, M.D., Ph.D., Neapolitan Oncologist, Director of the Sbarro Institute for Cancer Research at Temple University and founder of the Sbarro Health Research Organization (SHRO), met today with Congresswoman Rosa DeLauro...
5-Nov-2021 2:55 PM EDT Add to Favorites
Research Supports More Effective Choices Than Ever for Drug-Free Pain Relief During Labor and Delivery
Researchers coordinated by Professor Antonio Giordano, M.D., Ph.D., Founder and Director of the Sbarro Health Research Organization (SHRO) have highlighted the effectiveness of non-pharmacological analgesic techniques during childbirth in a review...
4-Nov-2021 10:30 AM EDT Add to Favorites
NIAF Board Member and SHRO Director Antonio Giordano leads scholarship committee.
28-Oct-2021 9:00 AM EDT Add to Favorites
Elucidation of Novel mechanisms regulating the tumor suppressor RBL1/p107 levels in mesothelioma and lung cancer cells
8-Oct-2021 3:40 PM EDT Add to Favorites
Fungal and Bacterial Biodeterioration of Outdoor Canvas Paintings: The Case of the Cloisters of Quito, Ecuador
The journal Critical Review In Eukaryotic Gene Expression has just published an interesting article entitled: “Fungal And Bacterial Biodeterioration Of Outdoor Canvas Paintings: The Case Of The Cloisters Of Quito, Ecuador.”
25-Aug-2021 5:30 PM EDT Add to Favorites
GYNOCARE COST Creates International Research Collab on Rare Cancers Affecting Millions of Women Annually
Sbarro Health Research Organization (SHRO) Founder and Director, Antonio Giordano, M.D., Ph.D., of Temple University and the University of Siena, Italy, is part of the GYNOCARE COST Action (CA18117) chaired by Prof Jean Calleja Agius of the...
20-Aug-2021 2:45 PM EDT Add to Favorites
See All News
2-Mar-2021 8:15 AM EST
3-Nov-2020 2:35 PM EST
4-Jun-2020 9:55 AM EDT
COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST
16-Jan-2018 11:05 AM EST
Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST